Technical / White Paper
New FDA GRAS brain magnesium technical brief and clinical research review
This comprehensive technical paper provides an in-depth review of four published cognitive research studies on the novel brain magnesium compound, Magtein. Patented Magtein™ is the only form of magnesium to effectively cross the blood brain barrier. The research demonstrates Magtein’s ability to improve short-term and long-term memory, recognition and learning, as well as alleviating anxiety in animal models plus the ability to reduce brain plaque. Magtein is now FDA GRAS making it ideal for a cognitive functional food or beverage. Beverage application studies are included. A robust human clinical is being prepared for publication and can be shared by contacting AIDP at customercare@aidp.com.
